On 17 JULY Linear Technology Corporation (NASDAQ:LLTC) said that it is again eyeing Camas for a major expansion, and a decision could come later this summer. Linear Technology Corporation (NASDAQ:LLTC) belongs to Technology sector. Its net profit margin is 33.10% and weekly performance is -2.38%. On last trading day company shares ended up $44.25. Linear Technology Corporation (NASDAQ:LLTC) distance from 50-day simple moving average (SMA50) is -4.80%.

Technical Communications Corporation (NASDAQ:TCCO) on 13 May 2014 announced its results for the three and six months ended March 29, 2014. For the second quarter of the Company’s 2014 fiscal year, the Company reported a net loss of ($1,467,000), or ($0.80) per share, on revenue of $1,293,000, compared to a net loss of ($328,000), or ($0.18) per share, on revenue of $546,000 for the quarter ended March 30, 2013. For the six months ended March 29, 2014, the Company reported a net loss of ($1,282,000), or ($0.70) per share, on revenue of $3,802,000, compared to a net loss of ($638,000), or ($0.35) per share, on revenue of $2,142,000 for the six months ended March 30, 2013. Technical Communications Corporation (NASDAQ:TCCO) shares increased 3.80% in last trading session and ended the day at $3.89. TCCO Gross Margin is 65.80% and its return on assets is -11.80%. Technical Communications Corporation (NASDAQ:TCCO) quarterly performance is -34.25%.

Vaalco Energy Inc. (NYSE:EGY) today announced that it will hold a conference call to discuss its second quarter 2014 results on Thursday, August 7, 2014, at 10:00 a.m. Central Time (11:00 a.m. Eastern Time).  On 06 August, Vaalco Energy Inc. (NYSE:EGY) shares increased 3.34% and was closed at $7.12. EGY EPS growth in last 5 year was 8.20%. Vaalco Energy Inc. (NYSE:EGY) year to date (YTD) performance is 3.34%.

INSYS Therapeutics, Inc. (NASDAQ:INSY) announced that the Company will release its financial results for the second quarter 2014 on Tuesday, August 12, 2014, before the U.S. financial markets open. Following the release of the financial results, Michael L. Babich, President and Chief Executive Officer, and Darryl S. Baker, Chief Financial Officer, will host a conference call at 11:00 a.m. Eastern Daylight Time. INSYS Therapeutics, Inc. (NASDAQ:INSY) ended the last trading day at $27.15. Company weekly volatility is calculated as 8.48%and price to cash ratio as 19.82. INSYS Therapeutics, Inc. (NASDAQ:INSY) showed a weekly performance of -9.73%.

Evogene Ltd. and Marrone Bio Innovations Inc. (NASDAQ:MBI) have signed a multi-year collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new pest control products by each company. Marrone Bio Innovations, Inc. (NASDAQ:MBII) shares increased 4.78% in last trading session and ended the day on $9.65. MBII Gross Margin is 27.40% and its return on assets is -50.20%. Marrone Bio Innovations, Inc. (NASDAQ:MBII) quarterly performance is -13.38%.